Host: John J. Russell, MD

Guest: Abdul Abdellatif, MD, FASN

Guest: Debbie Glidden, MSN, APRN-BC, CNN

How can you control the administration of calcimimetics for your patients with chronic kidney disease who are on hemodialysis and suffering from secondary hyperparathyroidism, also known as sHPT? John Russell, MD sits down with two community nephrology professionals, Adbul Abdellatif, MD, FASN from Houston, Texas, and Debbie Glidden, MSN, APRN-BC, CNN from Orlando, Florida. They will be discussing a dosing practice involving oral cinacalcet and what alternatives they suggest for nephrologists who are concerned about controlling the administration of sHPT treatment in an approved fashion.

This promotional, non-CME program is intended for US Health Care Professionals. Adbul Abdellatif, MD, FASN and Debbie Glidden, MSN, APRN-BC, CNN were paid a fee by Amgen for their participation in the program.